Sequencing T-cells in Type I Diabetes Mellitus

Tumor Lysate Pulsed Dendritic Cell Immunotherapy for Patients With Brain Tumors

NCT00576537 ·Status: COMPLETED ·Phase: PHASE2

Autologous Dendritic Cell Therapy for Type 1 Diabetes Suppression: A Safety Study

NCT00445913 ·Status: COMPLETED ·Phase: PHASE1

Identification of Pathways to Mitigate Immune-Related Adverse Events With Cancer Immunotherapy

NCT04283539 ·Status: RECRUITING

Neoantigen-expanded Autologous Immune Cell Therapy

NCT05020119 ·Status: UNKNOWN ·Phase: PHASE1

Immunization Against Tumor Cells in Sezary Syndrome

NCT00099593 ·Status: COMPLETED ·Phase: PHASE2

Effect of Denileukin Diftitox on Immune System in CTCL Patients

NCT00254332 ·Status: COMPLETED

Immune Responses to Autologous Langerhans-type Dendritic Cells Electroporated With mRNA Encoding a Tumor-associated Antigen in Patients With Malignancy: A Single-arm Phase I Trial in Melanoma

NCT01456104 ·Status: COMPLETED ·Phase: PHASE1

Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System

NCT00001158 ·Status: COMPLETED

A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors

NCT02318394 ·Status: COMPLETED ·Phase: PHASE1

Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes

NCT02081326 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT03735589 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Collection and Generation of Antigen-specific T-lymphocyte Cell Lines From Primary, Third-party, Related, and Unrelated Donors

NCT03114566 ·Status: TERMINATED

Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients

NCT00085930 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of Regulatory T Cells in Treating Autoimmune Hepatitis

NCT02704338 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Clinical Evaluations and Laboratory Studies to Study the Disease Course in Patients With Cutaneous T-Cell Lymphoma

NCT00430053 ·Status: COMPLETED

Personalized TCR-T: Study of Adoptively Transferred T-cell Receptor Gene-engineered T Cells (TCR-T)

NCT05349890 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs

NCT05292859 ·Status: COMPLETED

Biological Therapy in Treating Patients With Advanced Cancer

NCT00005956 ·Status: COMPLETED ·Phase: NA

Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma

NCT00576641 ·Status: COMPLETED ·Phase: PHASE1

Autologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic Melanoma

NCT01875653 ·Status: TERMINATED ·Phase: PHASE3

Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer

NCT00795977 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Functional Plasticity of Human IL-17-producing CD8+ T Cells

NCT03291639 ·Status: COMPLETED

Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast Cancer

NCT03113019 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

T-cell Therapy with CRISPR PD1-edited Tumor Infiltrating Lymphocytes for Patients with Metastatic Melanoma

NCT06783270 ·Status: RECRUITING ·Phase: PHASE1

Study of Polyfunctionality of Anti-tumor T Lymphocytes in Cancerology: Potential Biomarker for Emerging Immunotherapies

NCT02880046 ·Status: UNKNOWN